RA Capital Management buys USD 6.84 million of Parabilis Medicines common shares
PBLS•RA Capital increases Parabilis Medicines stake
RA Capital Management, a director-level 10% owner, increased its stake in Parabilis Medicines through open-market purchases.
Holdings rose to 26,529,686 shares held indirectly by RA Capital Healthcare Fund.
An additional 2,648,278 shares were reported as held indirectly by RA Capital Nexus Fund III.
Purchases were disclosed at weighted-average prices ranging from $27.13 to $30.
